US Stock MarketDetailed Quotes

TARS Tarsus Pharmaceuticals

Watchlist
  • 33.890
  • +1.620+5.02%
Close Oct 4 16:00 ET
  • 33.890
  • 0.0000.00%
Post 16:02 ET
1.29BMarket Cap-7598P/E (TTM)

Tarsus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tarsus Pharmaceuticals Q2 2024 Earnings Date

Currency：USDAug 8, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
32.05M
40.81M
+8.77M
Beat Est.
--
--
+27.35%
EPS
-0.96
-0.88
+0.08
Beat Est.
+17.58%
+24.79%
+8.73%
Analyst Rating
Strong Buy

Oct 4, 2024

Tarsus Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 51.866M--
--2024/Q3-- / 43.333M--
Aug 8, 20242024/Q240.813M / 32.048M--
May 8, 20242024/Q127.614M / 17.898M--
Feb 27, 20242023/Q413.076M / 5.924M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 51.866M--
--2024/Q3-- / 43.333M--
Aug 8, 20242024/Q240.813M / 32.048M--
May 8, 20242024/Q127.614M / 17.898M--
Feb 27, 20242023/Q413.076M / 5.924M--

Unlock Free Earnings Estimates

Tarsus Pharmaceuticals Earnings Reports

  • Tarsus Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 8 16:21 ET

  • Tarsus Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 8 17:19 ET

  • Tarsus Pharmaceuticals | 10-K: FY2023 Annual Report

    Feb 27 16:10 ET

  • Tarsus Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 9, 2023 16:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 4, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data